{"status":"success","message":"The QUALITY_ASSURE field for indicator 3-3-5, translated into en","data":"<h2>Quality assurance:</h2>\n<p>Training materials for the Integrated NTD database are available here: <a href=\"http://www.who.int/neglected_diseases/data/ntddatabase/en/\">http://www.who.int/neglected_diseases/data/ntddatabase/en/</a>. A user guide and video tutorial for the joint reporting mechanism and set of reporting forms are available here: <a href=\"http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/\">http://www.who.int/neglected_diseases/preventive_chemotherapy/reporting/en/</a></p>\n<p>Details about individual NTD data are available via: <a href=\"http://www.who.int/gho/neglected_diseases/en/\">http://www.who.int/gho/neglected_diseases/en/</a>. For NTDs requiring preventive chemotherapy, reports are signed by the NTD coordinator or a Ministry of Health representative to formally endorse the country&#x2019;s request for medicines (when applicable) and data. They are submitted to the WHO Representative of the concerned WHO Country office.</p>"}